Program Description
Chronic kidney disease (CKD) is a progressive, life-threatening condition that
often coexists with and is significantly worsened by type 2 diabetes (T2D).
These interconnected conditions pose significant challenges related to
screening, diagnosis, and evidence-based treatment. This webinar will examine
the challenges and gaps in CKD management, including issues of underdiagnosis
and undertreatment as well as the latest treatment guidelines and recent
clinical data supporting novel pharmacotherapies. A key focus will be a
detailed discussion of sodium-glucose cotransporter 2 inhibitors and
glucagon-like peptide-1 receptor agonists, including data from pivotal clinical
trials highlighting their cardiorenal benefits beyond glycemic control. The
program will also explore the pharmacist's vital role in optimizing
cardiorenal-metabolic care, from implementing screening strategies and ensuring
medication access to monitoring outcomes and coordinating team-based care.
Target Audience: Ambulatory care, health system, and specialty
pharmacist
Type
of Activity: Application
Release date: December 19, 2025
Expiration date: December 19, 2026
Learner level: Foundational and intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify patients at increased risk for chronic kidney disease (CKD) and apply guideline-based recommendations for early screening using urine albumin-to-creatinine ratio and estimated glomerular filtration rate
- Explain the cardiovascular risks associated with early-stage CKD and the need for prompt and appropriate intervention
- Determine the role of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in managing CKD and reducing cardiovascular risk
- Apply multidisciplinary, team-based approaches to care for patients with cardiorenal-metabolic comorbidities
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here